TLR9 and cervical carcinoma: Furthermore, the TLR4 haplotype GTAC [p = 0.047, OR = 1.77 (1.00–3.13)] and TLR9 haplotype GATC [p = 0.019, OR = 3.95 (1.15–13.50)] were found to be associated with the increased risk of cervical cancer whereas the TLR4 haplotype GCAG [p = 0.0076, OR = 0.39 (0.19–0.79)] was significantly associated with decreased risk of cervical cancer.